Tetrahydrozoline (HCl)

Tetrahydrozoline (HCl) is 2-(1, 2, 3, 4-tetrahydro-1-naphthyl)-2-imidazoline. It is used as a nasal and ophthalmologic decongestant. It is used in the eye to relieve redness, burning and irritation due to dry eyes, allergies or minor irritations.

Tetrahydrozoline (HCl) is primarily indicated in conditions like Conjunctival congestion.

Tetrahydrozoline (HCl) is contraindicated in conditions like Neonates, Hypersensitivity to any component of product.

The severe or irreversible adverse effects of Tetrahydrozoline (HCl), which give rise to further complications include Hypertension, Palpitation. The symptomatic adverse reactions produced by Tetrahydrozoline (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Tremors, Blurred vision, Sneezing, Stinging on application.

Use topical decongestant (tetrahydrozoline) only in acute conditions, not longer than 3 to 5 days. It should be use sparingly in all patients, especially in infants, children and in cardiac patients. Avoid in Narrow angle Glaucoma, May cause temporary mydriasis, Use caution in hypertension, CAD, DM and hyperthyroidism.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

0.02 to 0.07 % (0.045 (0.045)) As recommended. Ophthalmic — drops. 0.02 to 0.07 mg (0.045 (0.045)) 8 hourly Ophthalmic — -

SA ( ) —

No neonatal dosage information is recorded for this medicine yet.

No data regarding the interactions of Tetrahydrozoline (HCl) was found.

Nasal Spray, Nasal Drops Store Below 40°C. Protect from Sunlight and Heat.